{"id":2970,"date":"2021-11-23T08:23:16","date_gmt":"2021-11-23T08:23:16","guid":{"rendered":"https:\/\/aceoncology.org\/?p=2970"},"modified":"2021-11-23T08:23:18","modified_gmt":"2021-11-23T08:23:18","slug":"practice-changing-results-for-sunitinib-in-malignant-pheochromocytomas-and-paragangliomas","status":"publish","type":"post","link":"https:\/\/aceoncology.org\/zh-hans\/practice-changing-results-for-sunitinib-in-malignant-pheochromocytomas-and-paragangliomas\/","title":{"rendered":"\u8212\u5c3c\u66ff\u5c3c\u662f\u6076\u6027\u55dc\u94ec\u7ec6\u80de\u7624\/\u526f\u795e\u7ecf\u8282\u7624\u7684\u6709\u6548\u6cbb\u7597\u9009\u62e9"},"content":{"rendered":"\n<p>\u55dc\u94ec\u7ec6\u80de\u7624\u548c\u526f\u795e\u7ecf\u8282\u7624\uff08PPs\uff09\u662f\u7f55\u89c1\u7684\u795e\u7ecf\u5185\u5206\u6ccc\u7624\uff0c\u5206\u522b\u8d77\u6e90\u4e8e\u80be\u4e0a\u817a\u9ad3\u8d28\u7684\u55dc\u94ec\u7ec6\u80de\u6216\u80be\u4e0a\u817a\u5916\u81ea\u4e3b\u795e\u7ecf\u526f\u795e\u7ecf\u8282\u3002\u5927\u591a\u6570PPs\u4e3a\u826f\u6027\uff0c\u5e76\u53ef\u901a\u8fc7\u624b\u672f\u6210\u529f\u6cbb\u7597\u3002\u7136\u800c\uff0c\u5c11\u6570\u60a3\u8005\uff08&lt; 1\/100\u4e07\u4eba\uff09\u88ab\u8bca\u65ad\u4e3a\u6076\u6027PPs\uff08MPPs\uff09\uff0c\u4e16\u754c\u536b\u751f\u7ec4\u7ec7\u5c06\u5176\u5b9a\u4e49\u4e3a\u5b58\u5728\u975e\u55dc\u94ec\u5668\u5b98\u8f6c\u79fb\u7684PPs\uff0c\u6700\u5e38\u89c1\u4e8e\u9aa8\u3001\u809d\u3001\u80ba\u548c\u6dcb\u5df4\u7ed3\u3002MPPs\u60a3\u8005\u7684\u9884\u540e\u5404\u4e0d\u76f8\u540c\uff0c<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/31599769\/\">5\u5e74\u751f\u5b58\u7387\u4e3a40%\uff5e85%<\/a>\u3002SDHB\u7a81\u53d8\u548c\u539f\u53d1\u80bf\u7624\u5927\u5c0f\u7684\u5b58\u5728\u662f\u4e0d\u826f\u9884\u540e\u56e0\u7d20\u3002MPP\u7684\u7ba1\u7406\u5177\u6709\u6311\u6218\u6027\uff0c\u5b58\u5728\u8f83\u5927\u7684\u672a\u6ee1\u8db3\u6cbb\u7597\u9700\u6c42\uff0c\u9700\u8981\u66f4\u597d\u7684\u6cbb\u7597\u65b9\u6848\u6765\u586b\u8865\u3002\u8fd9\u4e9b\u80bf\u7624\u8840\u7ba1\u4e30\u5bcc\uff0c\u4e34\u5e8a\u524d\u548c\u65e9\u671f\u4e34\u5e8a\u6570\u636e\u8868\u660e\u8840\u7ba1\u751f\u6210\u9776\u5411\u916a\u6c28\u9178\u6fc0\u9176\u6291\u5236\u5242\uff08\u5982\u8212\u5c3c\u66ff\u5c3c\uff09\u5177\u6709\u6f5c\u5728\u6d3b\u6027\u3002<\/p>\n\n\n\n<p>\u5728\u4eca\u5e74\u7684ESMO\u5927\u4f1a\u4e0a\uff0c\u8212\u5c3c\u66ff\u5c3c\u6cbb\u7597MPP\u7597\u6548\u7684\u56fd\u9645\u3001\u53cc\u76f2\u3001\u968f\u673a\u3001II\u671f<a href=\"https:\/\/oncologypro.esmo.org\/meeting-resources\/esmo-congress-2021\/first-international-randomized-study-in-malignant-progressive-pheochromocytoma-and-paragangliomas-firstmappp-an-academic-double-blind-trial-inve\">FIRSTMAPPP\u7814\u7a76<\/a>\u7684\u7ed3\u679c\u7531\u6cd5\u56fd\u7ef4\u52d2\u745e\u592b\u7684\u53e4\u65af\u5854\u592b\u2022\u9c81\u897f\u764c\u75c7\u4e2d\u5fc3\u7684Eric Baudin\u535a\u58eb\u516c\u5e03\u3002\u517178\u4f8b\u4e0d\u53ef\u5207\u9664\u7684\u8fdb\u5c55\u6027MPP\u60a3\u8005\u57288\u5e74\u5185\u5165\u7ec4\u7814\u7a76\uff0c\u63a5\u53d7\u8212\u5c3c\u66ff\u5c3c\uff08n = 39\uff09\uff08\u8fde\u7eed\u7ed9\u836f37.5 mg\/\u5929\uff0c\u76f4\u81f3\u75be\u75c5\u8fdb\u5c55\uff09\u6216\u5b89\u6170\u5242\uff08n = 39\uff09\u6cbb\u7597\u3002\u5bf9\u4e8e\u63a5\u53d7\u5b89\u6170\u5242\u6cbb\u7597\u540e\u8fdb\u5c55\u7684\u60a3\u8005\uff0c\u5141\u8bb8\u4ea4\u53c9\u63a5\u53d7\u8212\u5c3c\u66ff\u5c3c\u6cbb\u7597\u3002\u60a3\u8005\u7279\u5f81\u5e73\u8861\u826f\u597d\uff1a\u5728\u6240\u6709\u60a3\u8005\u4e2d\uff0c32%\u6709SDHB\u7a81\u53d8\uff1b40%\u6709\u57fa\u7ebf\u9ad8\u8840\u538b\uff1b60%\u6709\u9aa8\u8f6c\u79fb\uff1b40%\u60a3\u8005\u4e3a\u4e00\u7ebf\u6cbb\u7597\u3002\u4e2d\u4f4d\u968f\u8bbf\u65f6\u95f4\u4e3a27.2\u4e2a\u6708\u3002\u8fbe\u5230\u4e86\u7814\u7a76\u7684\u4e3b\u8981\u7ec8\u70b9\uff0c\u8212\u5c3c\u66ff\u5c3c\u7ec4\u670935.9%\u7684\u60a3\u8005\u572812\u4e2a\u6708\u65f6\u8fbe\u5230\u65e0\u8fdb\u5c55\u751f\u5b58\u671f\uff08PFS\uff09\uff0c\u800c\u5b89\u6170\u5242\u7ec4\u4e3a18.9%\u3002\u57fa\u4e8e\u7814\u7a76\u7684\u7edf\u8ba1\u5b66\u8bbe\u8ba1\uff0c\u6570\u636e\u652f\u6301\u8212\u5c3c\u66ff\u5c3c\u7684\u7597\u6548\u3002\u4e2d\u4f4dPFS\u5206\u522b\u4e3a8.9\u4e2a\u6708\u548c3.6\u4e2a\u6708\uff0c\u8212\u5c3c\u66ff\u5c3c\u7ec431%\u7684\u60a3\u8005\u62a5\u544a\u4e3a\u90e8\u5206\u7f13\u89e3\uff08PR\uff09\uff0c\u6cbb\u7597\u6301\u7eed\u65f6\u95f4\u4e3a11\u4e2a\u6708\uff0c\u800c\u5b89\u6170\u5242\u7ec4\u5206\u522b\u4e3a8%\u548c4\u4e2a\u6708\u3002\u503c\u5f97\u6ce8\u610f\u7684\u662f\uff0c\u5728SDHB\u7a81\u53d8\u80bf\u7624\u60a3\u8005\u4e2d\u62a5\u544a\u4e86\u66f4\u591a\u7684PR\uff0850%vs. 26%\uff09\uff0cPR\u5e76\u4e0d\u5c40\u9650\u4e8e\u4ec5\u6709SDHB\u7a81\u53d8\u80bf\u7624\u7684\u60a3\u8005\u3002\u5b89\u6170\u5242\u7ec4\u5927\u591a\u6570\u60a3\u8005\uff0887%\uff09\u5728\u75be\u75c5\u8fdb\u5c55\u65f6\u4ea4\u53c9\u63a5\u53d7\u8212\u5c3c\u66ff\u5c3c\u6cbb\u7597\u3002\u8212\u5c3c\u66ff\u5c3c\u7ec4\u548c\u5b89\u6170\u5242\u7ec4\u4e2d\u62a5\u544a\u22653\u7ea7\u4e0d\u826f\u4e8b\u4ef6\uff08AE\uff09\u7684\u60a3\u8005\u6bd4\u4f8b\u5206\u522b\u4e3a72%\u548c51%\uff1b\u6700\u5e38\u89c1\u76843-4\u7ea7AE\u4e3a\u4e4f\u529b\/\u75b2\u4e4f\uff0818%\u548c3%\uff09\u548c\u9ad8\u8840\u538b\uff0810%\u548c6%\uff09\uff1b\u8212\u5c3c\u66ff\u5c3c\u7ec4\u548c\u5b89\u6170\u5242\u7ec4\u5206\u522b\u67093\u4f8b\uff081\u4f8b\u4e0e\u6cbb\u7597\u4e0d\u76f8\u5173\uff09\u548c1\u4f8b\u6b7b\u4ea1\u3002<\/p>\n\n\n\n<p>Baudin\u535a\u58eb\u5f97\u51fa\u7ed3\u8bba\uff0c\u8212\u5c3c\u66ff\u5c3c\u663e\u793a\u4e86\u201c\u5728\u8fdb\u5c55\u6027MPP\u4e2d\u6297\u80bf\u7624\u6d3b\u6027\u7684\u6700\u6709\u529b\u8bc1\u636e\u201d\uff0c\u6b64\u7ed3\u8bba\u5c06\u6539\u53d8MPP\u7684\u4e34\u5e8a\u6cbb\u7597\u3002\u7814\u7a76\u7684\u8ba8\u8bba\u5609\u5bbe\u897f\u73ed\u7259\u9a6c\u5fb7\u91cc\u5927\u5b66\u533b\u9662Rocio Garcia-Carbonero\u535a\u58eb\u795d\u8d3a\u7814\u7a76\u8005\u5728MPP\u9886\u57df\u8fdb\u884c\u4e86\u7b2c\u4e00\u9879\u4e5f\u662f\u6700\u5927\u7684\u4e00\u9879\u968f\u673a\u7814\u7a76\uff0c\u4e3a\u8fd9\u79cd\u975e\u5e38\u7f55\u89c1\u7684\u80bf\u7624\u63d0\u4f9b\u4e86\u6700\u9ad8\u6c34\u5e73\u7684\u8bc1\u636e\u3002\u5979\u5f3a\u8c03\uff0c\u8be5\u7814\u7a76\u8bc1\u660e\u4e86\u5408\u4f5c\u5b66\u672f\u7814\u7a76\u7684\u91cd\u8981\u6027\uff0c\u5e76\u540c\u610fBaudin\u535a\u58eb\u7684\u89c2\u70b9\uff0c\u5373\u8be5\u7814\u7a76\u7ed3\u679c\u5c06\u6539\u53d8\u4e34\u5e8a\u5b9e\u8df5\u3002<\/p>\n\n\n\n<p><strong>Reference<br><\/strong>Baudin E\uff0c et al. <em>ESMO <\/em>2021\uff1b Abstract 5670_PR.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u55dc\u94ec\u7ec6\u80de\u7624\u548c\u526f\u795e\u7ecf\u8282\u7624\uff08PPs\uff09\u662f\u7f55\u89c1\u7684\u795e\u7ecf\u5185\u5206\u6ccc\u7624\uff0c\u5206\u522b\u8d77\u6e90\u4e8e\u80be\u4e0a\u817a\u9ad3\u8d28\u7684\u55dc\u94ec\u7ec6\u80de\u6216\u80be\u4e0a\u817a\u5916\u81ea\u4e3b\u795e\u7ecf\u526f\u795e\u7ecf\u8282 [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":2960,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[78],"tags":[],"class_list":["post-2970","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-78"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>\u8212\u5c3c\u66ff\u5c3c\u662f\u6076\u6027\u55dc\u94ec\u7ec6\u80de\u7624\/\u526f\u795e\u7ecf\u8282\u7624\u7684\u6709\u6548\u6cbb\u7597\u9009\u62e9 - ACE Oncology<\/title>\n<meta name=\"description\" content=\"\u8212\u5c3c\u66ff\u5c3c\u662f\u6076\u6027\u55dc\u94ec\u7ec6\u80de\u7624\u548c\u526f\u795e\u7ecf\u8282\u7624\u7684\u6709\u6548\u6cbb\u7597\u9009\u62e9\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/aceoncology.org\/zh-hans\/practice-changing-results-for-sunitinib-in-malignant-pheochromocytomas-and-paragangliomas\/\" \/>\n<meta property=\"og:locale\" content=\"zh_CN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\u8212\u5c3c\u66ff\u5c3c\u662f\u6076\u6027\u55dc\u94ec\u7ec6\u80de\u7624\/\u526f\u795e\u7ecf\u8282\u7624\u7684\u6709\u6548\u6cbb\u7597\u9009\u62e9 - ACE Oncology\" \/>\n<meta property=\"og:description\" content=\"\u8212\u5c3c\u66ff\u5c3c\u662f\u6076\u6027\u55dc\u94ec\u7ec6\u80de\u7624\u548c\u526f\u795e\u7ecf\u8282\u7624\u7684\u6709\u6548\u6cbb\u7597\u9009\u62e9\" \/>\n<meta property=\"og:url\" content=\"https:\/\/aceoncology.org\/zh-hans\/practice-changing-results-for-sunitinib-in-malignant-pheochromocytomas-and-paragangliomas\/\" \/>\n<meta property=\"og:site_name\" content=\"ACE Oncology\" \/>\n<meta property=\"article:published_time\" content=\"2021-11-23T08:23:16+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-11-23T08:23:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/11\/Picture-Blog-Post-67-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1707\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"ACE Demo\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ace_oncology\" \/>\n<meta name=\"twitter:site\" content=\"@ace_oncology\" \/>\n<meta name=\"twitter:label1\" content=\"\u4f5c\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"ACE Demo\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 \u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/practice-changing-results-for-sunitinib-in-malignant-pheochromocytomas-and-paragangliomas\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/practice-changing-results-for-sunitinib-in-malignant-pheochromocytomas-and-paragangliomas\/\"},\"author\":{\"name\":\"ACE Demo\",\"@id\":\"https:\/\/aceoncology.org\/#\/schema\/person\/b551dd0a4b75a5b349e0a71560a8b3c0\"},\"headline\":\"\u8212\u5c3c\u66ff\u5c3c\u662f\u6076\u6027\u55dc\u94ec\u7ec6\u80de\u7624\/\u526f\u795e\u7ecf\u8282\u7624\u7684\u6709\u6548\u6cbb\u7597\u9009\u62e9\",\"datePublished\":\"2021-11-23T08:23:16+00:00\",\"dateModified\":\"2021-11-23T08:23:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/practice-changing-results-for-sunitinib-in-malignant-pheochromocytomas-and-paragangliomas\/\"},\"wordCount\":46,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/aceoncology.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/practice-changing-results-for-sunitinib-in-malignant-pheochromocytomas-and-paragangliomas\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/11\/Picture-Blog-Post-67-scaled.jpg\",\"articleSection\":[\"\u4f1a\u8bae\u901f\u9012\"],\"inLanguage\":\"zh-Hans\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/aceoncology.org\/zh-hans\/practice-changing-results-for-sunitinib-in-malignant-pheochromocytomas-and-paragangliomas\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/practice-changing-results-for-sunitinib-in-malignant-pheochromocytomas-and-paragangliomas\/\",\"url\":\"https:\/\/aceoncology.org\/zh-hans\/practice-changing-results-for-sunitinib-in-malignant-pheochromocytomas-and-paragangliomas\/\",\"name\":\"\u8212\u5c3c\u66ff\u5c3c\u662f\u6076\u6027\u55dc\u94ec\u7ec6\u80de\u7624\/\u526f\u795e\u7ecf\u8282\u7624\u7684\u6709\u6548\u6cbb\u7597\u9009\u62e9 - ACE Oncology\",\"isPartOf\":{\"@id\":\"https:\/\/aceoncology.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/practice-changing-results-for-sunitinib-in-malignant-pheochromocytomas-and-paragangliomas\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/practice-changing-results-for-sunitinib-in-malignant-pheochromocytomas-and-paragangliomas\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/11\/Picture-Blog-Post-67-scaled.jpg\",\"datePublished\":\"2021-11-23T08:23:16+00:00\",\"dateModified\":\"2021-11-23T08:23:18+00:00\",\"description\":\"\u8212\u5c3c\u66ff\u5c3c\u662f\u6076\u6027\u55dc\u94ec\u7ec6\u80de\u7624\u548c\u526f\u795e\u7ecf\u8282\u7624\u7684\u6709\u6548\u6cbb\u7597\u9009\u62e9\",\"breadcrumb\":{\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/practice-changing-results-for-sunitinib-in-malignant-pheochromocytomas-and-paragangliomas\/#breadcrumb\"},\"inLanguage\":\"zh-Hans\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/aceoncology.org\/zh-hans\/practice-changing-results-for-sunitinib-in-malignant-pheochromocytomas-and-paragangliomas\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/practice-changing-results-for-sunitinib-in-malignant-pheochromocytomas-and-paragangliomas\/#primaryimage\",\"url\":\"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/11\/Picture-Blog-Post-67-scaled.jpg\",\"contentUrl\":\"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/11\/Picture-Blog-Post-67-scaled.jpg\",\"width\":2560,\"height\":1707},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/practice-changing-results-for-sunitinib-in-malignant-pheochromocytomas-and-paragangliomas\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"ACE Oncology\",\"item\":\"https:\/\/aceoncology.org\/zh-hans\/chinese-home\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\u8212\u5c3c\u66ff\u5c3c\u662f\u6076\u6027\u55dc\u94ec\u7ec6\u80de\u7624\/\u526f\u795e\u7ecf\u8282\u7624\u7684\u6709\u6548\u6cbb\u7597\u9009\u62e9\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/aceoncology.org\/#website\",\"url\":\"https:\/\/aceoncology.org\/\",\"name\":\"ACE Oncology\",\"description\":\"ACE Oncology is a global independent medical education resource that provides evidence-based, high-quality educational solutions for clinicians that treat patients with cancer.\",\"publisher\":{\"@id\":\"https:\/\/aceoncology.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/aceoncology.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/aceoncology.org\/#organization\",\"name\":\"ACE Oncology\",\"url\":\"https:\/\/aceoncology.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\/\/aceoncology.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/05\/Logo.png\",\"contentUrl\":\"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/05\/Logo.png\",\"width\":156,\"height\":83,\"caption\":\"ACE Oncology\"},\"image\":{\"@id\":\"https:\/\/aceoncology.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/ace_oncology\",\"https:\/\/www.linkedin.com\/company\/aceoncology\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/aceoncology.org\/#\/schema\/person\/b551dd0a4b75a5b349e0a71560a8b3c0\",\"name\":\"ACE Demo\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\/\/aceoncology.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/5364d75bb683367c9b56b8d9914df888527c9d170b78bbc5ef94bb01125a2253?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/5364d75bb683367c9b56b8d9914df888527c9d170b78bbc5ef94bb01125a2253?s=96&d=mm&r=g\",\"caption\":\"ACE Demo\"},\"url\":\"https:\/\/aceoncology.org\/zh-hans\/author\/demo\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u8212\u5c3c\u66ff\u5c3c\u662f\u6076\u6027\u55dc\u94ec\u7ec6\u80de\u7624\/\u526f\u795e\u7ecf\u8282\u7624\u7684\u6709\u6548\u6cbb\u7597\u9009\u62e9 - ACE Oncology","description":"\u8212\u5c3c\u66ff\u5c3c\u662f\u6076\u6027\u55dc\u94ec\u7ec6\u80de\u7624\u548c\u526f\u795e\u7ecf\u8282\u7624\u7684\u6709\u6548\u6cbb\u7597\u9009\u62e9","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/aceoncology.org\/zh-hans\/practice-changing-results-for-sunitinib-in-malignant-pheochromocytomas-and-paragangliomas\/","og_locale":"zh_CN","og_type":"article","og_title":"\u8212\u5c3c\u66ff\u5c3c\u662f\u6076\u6027\u55dc\u94ec\u7ec6\u80de\u7624\/\u526f\u795e\u7ecf\u8282\u7624\u7684\u6709\u6548\u6cbb\u7597\u9009\u62e9 - ACE Oncology","og_description":"\u8212\u5c3c\u66ff\u5c3c\u662f\u6076\u6027\u55dc\u94ec\u7ec6\u80de\u7624\u548c\u526f\u795e\u7ecf\u8282\u7624\u7684\u6709\u6548\u6cbb\u7597\u9009\u62e9","og_url":"https:\/\/aceoncology.org\/zh-hans\/practice-changing-results-for-sunitinib-in-malignant-pheochromocytomas-and-paragangliomas\/","og_site_name":"ACE Oncology","article_published_time":"2021-11-23T08:23:16+00:00","article_modified_time":"2021-11-23T08:23:18+00:00","og_image":[{"width":2560,"height":1707,"url":"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/11\/Picture-Blog-Post-67-scaled.jpg","type":"image\/jpeg"}],"author":"ACE Demo","twitter_card":"summary_large_image","twitter_creator":"@ace_oncology","twitter_site":"@ace_oncology","twitter_misc":{"\u4f5c\u8005":"ACE Demo","\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4":"1 \u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/aceoncology.org\/zh-hans\/practice-changing-results-for-sunitinib-in-malignant-pheochromocytomas-and-paragangliomas\/#article","isPartOf":{"@id":"https:\/\/aceoncology.org\/zh-hans\/practice-changing-results-for-sunitinib-in-malignant-pheochromocytomas-and-paragangliomas\/"},"author":{"name":"ACE Demo","@id":"https:\/\/aceoncology.org\/#\/schema\/person\/b551dd0a4b75a5b349e0a71560a8b3c0"},"headline":"\u8212\u5c3c\u66ff\u5c3c\u662f\u6076\u6027\u55dc\u94ec\u7ec6\u80de\u7624\/\u526f\u795e\u7ecf\u8282\u7624\u7684\u6709\u6548\u6cbb\u7597\u9009\u62e9","datePublished":"2021-11-23T08:23:16+00:00","dateModified":"2021-11-23T08:23:18+00:00","mainEntityOfPage":{"@id":"https:\/\/aceoncology.org\/zh-hans\/practice-changing-results-for-sunitinib-in-malignant-pheochromocytomas-and-paragangliomas\/"},"wordCount":46,"commentCount":0,"publisher":{"@id":"https:\/\/aceoncology.org\/#organization"},"image":{"@id":"https:\/\/aceoncology.org\/zh-hans\/practice-changing-results-for-sunitinib-in-malignant-pheochromocytomas-and-paragangliomas\/#primaryimage"},"thumbnailUrl":"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/11\/Picture-Blog-Post-67-scaled.jpg","articleSection":["\u4f1a\u8bae\u901f\u9012"],"inLanguage":"zh-Hans","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/aceoncology.org\/zh-hans\/practice-changing-results-for-sunitinib-in-malignant-pheochromocytomas-and-paragangliomas\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/aceoncology.org\/zh-hans\/practice-changing-results-for-sunitinib-in-malignant-pheochromocytomas-and-paragangliomas\/","url":"https:\/\/aceoncology.org\/zh-hans\/practice-changing-results-for-sunitinib-in-malignant-pheochromocytomas-and-paragangliomas\/","name":"\u8212\u5c3c\u66ff\u5c3c\u662f\u6076\u6027\u55dc\u94ec\u7ec6\u80de\u7624\/\u526f\u795e\u7ecf\u8282\u7624\u7684\u6709\u6548\u6cbb\u7597\u9009\u62e9 - ACE Oncology","isPartOf":{"@id":"https:\/\/aceoncology.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/aceoncology.org\/zh-hans\/practice-changing-results-for-sunitinib-in-malignant-pheochromocytomas-and-paragangliomas\/#primaryimage"},"image":{"@id":"https:\/\/aceoncology.org\/zh-hans\/practice-changing-results-for-sunitinib-in-malignant-pheochromocytomas-and-paragangliomas\/#primaryimage"},"thumbnailUrl":"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/11\/Picture-Blog-Post-67-scaled.jpg","datePublished":"2021-11-23T08:23:16+00:00","dateModified":"2021-11-23T08:23:18+00:00","description":"\u8212\u5c3c\u66ff\u5c3c\u662f\u6076\u6027\u55dc\u94ec\u7ec6\u80de\u7624\u548c\u526f\u795e\u7ecf\u8282\u7624\u7684\u6709\u6548\u6cbb\u7597\u9009\u62e9","breadcrumb":{"@id":"https:\/\/aceoncology.org\/zh-hans\/practice-changing-results-for-sunitinib-in-malignant-pheochromocytomas-and-paragangliomas\/#breadcrumb"},"inLanguage":"zh-Hans","potentialAction":[{"@type":"ReadAction","target":["https:\/\/aceoncology.org\/zh-hans\/practice-changing-results-for-sunitinib-in-malignant-pheochromocytomas-and-paragangliomas\/"]}]},{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/aceoncology.org\/zh-hans\/practice-changing-results-for-sunitinib-in-malignant-pheochromocytomas-and-paragangliomas\/#primaryimage","url":"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/11\/Picture-Blog-Post-67-scaled.jpg","contentUrl":"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/11\/Picture-Blog-Post-67-scaled.jpg","width":2560,"height":1707},{"@type":"BreadcrumbList","@id":"https:\/\/aceoncology.org\/zh-hans\/practice-changing-results-for-sunitinib-in-malignant-pheochromocytomas-and-paragangliomas\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"ACE Oncology","item":"https:\/\/aceoncology.org\/zh-hans\/chinese-home\/"},{"@type":"ListItem","position":2,"name":"\u8212\u5c3c\u66ff\u5c3c\u662f\u6076\u6027\u55dc\u94ec\u7ec6\u80de\u7624\/\u526f\u795e\u7ecf\u8282\u7624\u7684\u6709\u6548\u6cbb\u7597\u9009\u62e9"}]},{"@type":"WebSite","@id":"https:\/\/aceoncology.org\/#website","url":"https:\/\/aceoncology.org\/","name":"ACE Oncology","description":"ACE Oncology is a global independent medical education resource that provides evidence-based, high-quality educational solutions for clinicians that treat patients with cancer.","publisher":{"@id":"https:\/\/aceoncology.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/aceoncology.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"zh-Hans"},{"@type":"Organization","@id":"https:\/\/aceoncology.org\/#organization","name":"ACE Oncology","url":"https:\/\/aceoncology.org\/","logo":{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/aceoncology.org\/#\/schema\/logo\/image\/","url":"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/05\/Logo.png","contentUrl":"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/05\/Logo.png","width":156,"height":83,"caption":"ACE Oncology"},"image":{"@id":"https:\/\/aceoncology.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/ace_oncology","https:\/\/www.linkedin.com\/company\/aceoncology"]},{"@type":"Person","@id":"https:\/\/aceoncology.org\/#\/schema\/person\/b551dd0a4b75a5b349e0a71560a8b3c0","name":"ACE Demo","image":{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/aceoncology.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/5364d75bb683367c9b56b8d9914df888527c9d170b78bbc5ef94bb01125a2253?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/5364d75bb683367c9b56b8d9914df888527c9d170b78bbc5ef94bb01125a2253?s=96&d=mm&r=g","caption":"ACE Demo"},"url":"https:\/\/aceoncology.org\/zh-hans\/author\/demo\/"}]}},"_links":{"self":[{"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/posts\/2970","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/comments?post=2970"}],"version-history":[{"count":1,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/posts\/2970\/revisions"}],"predecessor-version":[{"id":2971,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/posts\/2970\/revisions\/2971"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/media\/2960"}],"wp:attachment":[{"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/media?parent=2970"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/categories?post=2970"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/tags?post=2970"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}